SLGL
Sol Gel Technologies LtdNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage ready
Factor tilt: Momentum-tilted Micro Cap
$68.30-5.66%
Close Oct 13, 2026
- Market cap
- $223.38M
- 1 month
- +4.8%
- 3 months
- -11.5%
- 1 year
- +75.2%
- 52-week range
- $30.63$97.97
- Dividend
- No dividends on record
- Short interest
- 29.8% of float145.8K shares · settled Sep 30, 2026 · +19.3% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if SLGL is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
7 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Last 13F trend: distributing (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bullish
Last trade: buy 31 days ago
Red flags: 2
Largest 13-F holders · Q2 2026
23 filers reported a long position in SLGL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Opaleye Management Inc. | $37.1M | 500K | Unchanged |
| GREAT POINT PARTNERS LLC | $20.3M | 274.4K | Unchanged |
| Phoenix Financial Ltd. | $10.8M | 146.1K | -30.7% |
| Trails Edge Capital Partners, LP | $10.3M | 139.4K | +63.1% |
| Affinity Asset Advisors, LLC | $6.3M | 84.9K | +142.6% |
| Squadron Capital Management LLC | $3.9M | 52K | +67.7% |
| CITADEL ADVISORS LLC | $2.4M | 32.6K | -12.4% |
| GILDER GAGNON HOWE & CO LLC | $1.7M | 22.5K | New |
| Stonepine Capital Management, LLC | $1.1M | 14.5K | -47.9% |
| Yelin Lapidot Holdings Management Ltd. | $769.9K | 10.4K | -41.5% |
Get the Full Analysis for SLGL
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.